2026 SITC Spring Scientific: Next-generation Cellular Therapies, T cell Engagers, and Combinations

The 2026 SITC Spring Scientific will bring together experts in cell therapy, drug development, and immuno-oncology to address the timely topic of next-generation cellular therapies, T cell engagers, and combination therapies to treat cancer. The program will feature in-depth explorations and discussions of recent scientific breakthroughs, cutting-edge technologies, and the newest clinical studies that address the development and advancement of novel immuno-oncology agents and how these agents can be combined with other therapies to overcome tumor evasion of immunity.